7981 related articles for article (PubMed ID: 2194216)
21. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
22. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
23. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
26. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
28. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
29. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
[TBL] [Abstract][Full Text] [Related]
30. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of tumor-infiltrating lymphocyte in primary malignant lymphoma of the central nervous system using double immunofluorescence staining method].
Kunishio K; Matsuhisa T; Maeshiro T; Tsuno K; Shigematsu H; Mishima N; Matsumoto K; Furuta T; Ohmoto T; Nishimoto A
No To Shinkei; 1992 Feb; 44(2):125-30. PubMed ID: 1533133
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma.
Whelchel JC; Farah SE; McLean IW; Burnier MN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2603-6. PubMed ID: 8325762
[TBL] [Abstract][Full Text] [Related]
33. Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma.
Sheibani K; Battifora H; Winberg CD; Burke JS; Ben-Ezra J; Ellinger GM; Quigley NJ; Fernandez BB; Morrow D; Rappaport H
N Engl J Med; 1986 Apr; 314(15):943-8. PubMed ID: 3485768
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of B lymphocyte infiltration in breast cancer].
Yu H; Yang J; Jiao S; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):750-5. PubMed ID: 23689000
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte populations and TAC-antigen in diffuse B-cell lymphomas.
Grant BW; Platt JL; Jacob HS; Kay NE
Leuk Res; 1986; 10(11):1271-8. PubMed ID: 3099093
[TBL] [Abstract][Full Text] [Related]
36. Novel risk stratification of de novo diffuse large B cell lymphoma based on tumour-infiltrating T lymphocytes evaluated by flow cytometry.
Chen Z; Deng X; Ye Y; Gao L; Zhang W; Liu W; Zhao S
Ann Hematol; 2019 Feb; 98(2):391-399. PubMed ID: 30377764
[TBL] [Abstract][Full Text] [Related]
37. Characterization of activated lymphocytes in colon cancer.
Ebert EC; Brolin RE; Roberts AI
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):72-81. PubMed ID: 2783402
[TBL] [Abstract][Full Text] [Related]
38. [Assessment of the immunodeficiency of patients with lymphomata in relapse and in clinical remission (author's transl)].
Ruibal Ares B; Sasiain M; Brezavscek DM; Suarez A; Bachmann AE
Sangre (Barc); 1978; 23(5):535-43. PubMed ID: 311077
[No Abstract] [Full Text] [Related]
39. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype.
Lippman SM; Miller TP; Spier CM; Slymen DJ; Grogan TM
Blood; 1988 Aug; 72(2):436-41. PubMed ID: 3261181
[TBL] [Abstract][Full Text] [Related]
40. The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma.
Spier CM; Grogan TM; Lippman SM; Slymen DJ; Rybski JA; Miller TP
Am J Pathol; 1988 Oct; 133(1):118-26. PubMed ID: 3140668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
